Labcorp has been a great trade, beating the S&P 500 by 6.9%. Its stock price has climbed to $255.01, representing a healthy ...

Discover how FTRE's $7.7B backlog, CRO market growth, and focus on high-margin areas ensure long-term growth, efficiency, and ...

Charles River Labs (CRL) stock and LabCorp (LH) stock were upgraded and Quest Diagnostics (DGX) stock was downgraded at Citi.

Argus analyst David Toung raised the firm’s price target on Labcorp (LH) to $290 from $260 and keeps a Buy rating on the shares after its Q4 ...

Fintel reports that on March 4, 2025, Citigroup upgraded their outlook for Labcorp Holdings (NYSE:LH) from Neutral to Buy.

Labcorp Holdings Inc. LH, or Labcorp, is prioritizing key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, aiming to tap into strong growth opportunities.

Citi upgraded Labcorp (LH) to Buy from Neutral with a price target of $300, up from $250. Utilization rates have been running high ...

A vehicle crashed into the LabCorp business at 595 Loudon Rd in Newton Plaza II on March 4, causing significant damage to the ...

Texas doctors said there's no harm in getting another measles vaccine if you don't know whether you were vaccinated as a ...

Fintel reports that on March 4, 2025, Citigroup upgraded their outlook for Labcorp Holdings (NYSE:LH) from Neutral to Buy. As of February 19, 2025, the average one-year price target for Labcorp ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...